Numerous animal studies have suggested that the dysregulation of H4R3sme2 through downregulation of the PRMT5 protein level modifies the expression of target genes essential in cancer survival [84] and can selectively diversify the proteome via alternative splicing [85]. The gene discussed is PRMT5; the disease is cancer.